Paul Choi

Jul 30, 2026

Target

$90.00

Current

$76.27

Performance

-2.47%

Paul Choi rated KNSA as Buy on Jul 30, 2026, setting a price target of 90. Shares have remained stable near 76.27, leaving the 90 target still in play.

HCM

Jul 23, 2026

Target

$14.00

Current

$12.82

Performance

16.97%

On Jul 23, 2026, HCM was given a Neutral rating by Paul Choi, with a target price of 14. The stock rallied from 12.82 to 12.82 after the Hold rating, surprising to the upside.

EWTX

Jun 17, 2026

Target

$32.00

Current

$44.40

Performance

27.51%

EWTX received a Neutral rating from Paul Choi on Jun 17, 2026, aiming for 32. Investors saw gains of 27.51% that the cautious stance didn’t fully capture.

CRVS

Apr 17, 2026

Target

$40.00

Current

$12.91

Performance

-22.88%

On Apr 17, 2026, Paul Choi published a Buy outlook on CRVS, with a target of 40. Market action contradicted the Buy thesis, as shares slipped to 12.91.

RGNX

Feb 10, 2026

Target

$14.00

Current

$8.53

Performance

-3.62%

Paul Choi on Feb 10, 2026 assigned RGNX a Neutral rating, with a price target of 14. The Hold stance reflected consolidation, as shares held near 8.53.

VERA

Dec 19, 2025

Target

$95.00

Current

$35.05

Performance

-31.57%

On Dec 19, 2025, Paul Choi reaffirmed VERA with a Buy rating, targeting 95. Shares slid 31.57% despite the recommendation, highlighting downside risks.

CYTK

Dec 19, 2025

Target

$95.00

Current

$73.77

Performance

17.62%

CYTK was rated Buy by Paul Choi on Dec 19, 2025, with a price objective of 95. A bullish response from the market helped close the gap of 21.23 to the target.

PTCT

Nov 05, 2025

Target

$50.00

Current

$66.06

Performance

-7.96%

On Nov 05, 2025, Paul Choi initiated coverage on PTCT with a Sell rating and target of 50. Shares gained despite the bearish call, moving higher from 66.06.

BBIO

Oct 31, 2025

Target

$100.00

Current

$72.44

Performance

15.64%

Paul Choi issued a Buy recommendation for BBIO on Oct 31, 2025, price target set at 100. Investors following the Buy call captured upside momentum, with shares now at 72.44.

ARVN

Oct 15, 2025

Target

$6.00

Current

$8.45

Performance

-10.68%

On Oct 15, 2025, ARVN was evaluated by Paul Choi, who gave a Sell rating and target of 6. The recommendation was proven wrong by upward action toward 6.

LNTH

Oct 08, 2025

Target

$77.00

Current

$100.25

Performance

87.21%

Paul Choi rated LNTH as Neutral on Oct 08, 2025, setting a price target of 77. Despite the Hold call, shares climbed 87.21% to 100.25, revealing unexpected momentum.

EXEL

Sep 17, 2025

Target

$47.00

Current

$56.12

Performance

38.77%

On Sep 17, 2025, EXEL was given a Buy rating by Paul Choi, with a target price of 47. The stock rallied 38.77% after the rating, narrowing the gap to the target of 47 and validating the bullish stance.

AMRN

Jun 25, 2025

Target

$12.00

Current

$13.80

Performance

-14.76%

AMRN received a Sell rating from Paul Choi on Jun 25, 2025, aiming for 12. Investors who stayed short missed an upside surprise of -14.76%.

PHAT

Mar 10, 2025

Target

$12.00

Current

$8.36

Performance

90.00%

On Mar 10, 2025, Paul Choi published a Neutral outlook on PHAT, with a target of 12. The Hold call missed some of the bullish momentum as shares advanced toward 12.

ASND

Feb 13, 2025

Target

$225.00

Current

$263.51

Performance

84.94%

Paul Choi on Feb 13, 2025 assigned ASND a Buy rating, with a price target of 225. The Buy call aligned well with market performance, producing a gain of 84.94%.

DVAX

Feb 11, 2025

Target

$12.00

Current

$15.50

Performance

22.05%

On Feb 11, 2025, Paul Choi reaffirmed DVAX with a Sell rating, targeting 12. The Sell recommendation anticipated weakness, as shares dropped 22.05%.

ESPR

Dec 18, 2024

Target

$4.00

Current

$3.18

Performance

47.22%

ESPR was rated Neutral by Paul Choi on Dec 18, 2024, with a price objective of 4. Despite caution, upside momentum rewarded risk-takers with gains to 3.18.

GOSS